Vera Therapeutics drug meets all endpoints in two-year IgAN trial
Go back to Vera Therapeutics drug meets all endpoints in two-year IgAN trial| Veramark Technologies, Inc. (NASDAQ: VERA) | Delayed: 34.00 -0.27 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.27 | 52 Week High | $1.18 | |||
| Open | $34.56 | 52 Week Low | $0.36 | |||
| Day High | $34.56 | P/E | 566.67 | |||
| Day Low | $33.08 | EPS | $0.06 | |||
| Volume | 4,191,152 | |||||
